288 related articles for article (PubMed ID: 24359082)
1. Mass spectrometric characterization of transglutaminase based site-specific antibody-drug conjugates.
Farias SE; Strop P; Delaria K; Galindo Casas M; Dorywalska M; Shelton DL; Pons J; Rajpal A
Bioconjug Chem; 2014 Feb; 25(2):240-50. PubMed ID: 24359082
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminase-based chemo-enzymatic conjugation approach yields homogeneous antibody-drug conjugates.
Dennler P; Chiotellis A; Fischer E; Brégeon D; Belmant C; Gauthier L; Lhospice F; Romagne F; Schibli R
Bioconjug Chem; 2014 Mar; 25(3):569-78. PubMed ID: 24483299
[TBL] [Abstract][Full Text] [Related]
3. Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugates.
Strop P; Liu SH; Dorywalska M; Delaria K; Dushin RG; Tran TT; Ho WH; Farias S; Casas MG; Abdiche Y; Zhou D; Chandrasekaran R; Samain C; Loo C; Rossi A; Rickert M; Krimm S; Wong T; Chin SM; Yu J; Dilley J; Chaparro-Riggers J; Filzen GF; O'Donnell CJ; Wang F; Myers JS; Pons J; Shelton DL; Rajpal A
Chem Biol; 2013 Feb; 20(2):161-7. PubMed ID: 23438745
[TBL] [Abstract][Full Text] [Related]
4. Antibody structural integrity of site-specific antibody-drug conjugates investigated by hydrogen/deuterium exchange mass spectrometry.
Pan LY; Salas-Solano O; Valliere-Douglass JF
Anal Chem; 2015 Jun; 87(11):5669-76. PubMed ID: 25938577
[TBL] [Abstract][Full Text] [Related]
5. Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system.
Zimmerman ES; Heibeck TH; Gill A; Li X; Murray CJ; Madlansacay MR; Tran C; Uter NT; Yin G; Rivers PJ; Yam AY; Wang WD; Steiner AR; Bajad SU; Penta K; Yang W; Hallam TJ; Thanos CD; Sato AK
Bioconjug Chem; 2014 Feb; 25(2):351-61. PubMed ID: 24437342
[TBL] [Abstract][Full Text] [Related]
6. Linker technologies for antibody-drug conjugates.
Nolting B
Methods Mol Biol; 2013; 1045():71-100. PubMed ID: 23913142
[TBL] [Abstract][Full Text] [Related]
7. Site-Specific Antibody-Drug Conjugation Using Microbial Transglutaminase.
Dickgiesser S; Deweid L; Kellner R; Kolmar H; Rasche N
Methods Mol Biol; 2019; 2012():135-149. PubMed ID: 31161507
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the construction of antibody-drug conjugates.
Chudasama V; Maruani A; Caddick S
Nat Chem; 2016 Feb; 8(2):114-9. PubMed ID: 26791893
[TBL] [Abstract][Full Text] [Related]
9. Current methods for the synthesis of homogeneous antibody-drug conjugates.
Sochaj AM; Świderska KW; Otlewski J
Biotechnol Adv; 2015 Nov; 33(6 Pt 1):775-84. PubMed ID: 25981886
[TBL] [Abstract][Full Text] [Related]
10. Site-specific antibody-drug conjugation through glycoengineering.
Zhou Q; Stefano JE; Manning C; Kyazike J; Chen B; Gianolio DA; Park A; Busch M; Bird J; Zheng X; Simonds-Mannes H; Kim J; Gregory RC; Miller RJ; Brondyk WH; Dhal PK; Pan CQ
Bioconjug Chem; 2014 Mar; 25(3):510-20. PubMed ID: 24533768
[TBL] [Abstract][Full Text] [Related]
11. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
[TBL] [Abstract][Full Text] [Related]
12. Advances in the Development of Site-Specific Antibody-Drug Conjugation.
Zhou Q; Kim J
Anticancer Agents Med Chem; 2015; 15(7):828-36. PubMed ID: 25731178
[TBL] [Abstract][Full Text] [Related]
13. Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar.
Zhu Z; Ramakrishnan B; Li J; Wang Y; Feng Y; Prabakaran P; Colantonio S; Dyba MA; Qasba PK; Dimitrov DS
MAbs; 2014; 6(5):1190-200. PubMed ID: 25517304
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G
J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158
[TBL] [Abstract][Full Text] [Related]
15. Site-Specific Conjugation of Native Antibodies Using Engineered Microbial Transglutaminases.
Dickgiesser S; Rieker M; Mueller-Pompalla D; Schröter C; Tonillo J; Warszawski S; Raab-Westphal S; Kühn S; Knehans T; Könning D; Dotterweich J; Betz UAK; Anderl J; Hecht S; Rasche N
Bioconjug Chem; 2020 Apr; 31(4):1070-1076. PubMed ID: 32134638
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase-Mediated Conjugations.
Anami Y; Tsuchikama K
Methods Mol Biol; 2020; 2078():71-82. PubMed ID: 31643050
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in transglutaminase-mediated assembly of antibody-drug conjugates.
Schneider H; Deweid L; Avrutina O; Kolmar H
Anal Biochem; 2020 Apr; 595():113615. PubMed ID: 32035039
[TBL] [Abstract][Full Text] [Related]
18. Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry.
Xu K; Liu L; Saad OM; Baudys J; Williams L; Leipold D; Shen B; Raab H; Junutula JR; Kim A; Kaur S
Anal Biochem; 2011 May; 412(1):56-66. PubMed ID: 21216214
[TBL] [Abstract][Full Text] [Related]
19. Conjugation site analysis of antibody-drug-conjugates (ADCs) by signature ion fingerprinting and normalized area quantitation approach using nano-liquid chromatography coupled to high resolution mass spectrometry.
Sang H; Lu G; Liu Y; Hu Q; Xing W; Cui D; Zhou F; Zhang J; Hao H; Wang G; Ye H
Anal Chim Acta; 2017 Feb; 955():67-78. PubMed ID: 28088282
[TBL] [Abstract][Full Text] [Related]
20. Trisulfide modification impacts the reduction step in antibody-drug conjugation process.
Cumnock K; Tully T; Cornell C; Hutchinson M; Gorrell J; Skidmore K; Chen Y; Jacobson F
Bioconjug Chem; 2013 Jul; 24(7):1154-60. PubMed ID: 23713462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
